Julien Detour
University of Strasbourg
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julien Detour.
The Journal of Nuclear Medicine | 2014
Alessio Imperiale; Edmond Rust; Sophie Gabriel; Julien Detour; Bernard Goichot; Bernard Duclos; Jean-Emmanuel Kurtz; Philippe Bachellier; Izzie-Jacques Namer; David Taïeb
This work was performed to evaluate the performance of 18F-fluorodihydroxyphenylalanine (18F-FDOPA) PET/CT in detecting primary neuroendocrine tumors (NETs) occult on morphologic and functional imaging, in relation to tumor origin and differentiation. Methods: A retrospective study of NET patients who were investigated with 18F-FDOPA PET/CT imaging in 2 academic endocrine tumor centers was conducted. Only patients with negative conventional and somatostatin receptor scintigraphy (SRS) results were studied. Results: Twenty-seven patients were evaluated with 18F-FDOPA PET/CT, 23 at their initial staging and 4 during their follow-up. The primary occult NET was localized by 18F-FDOPA PET/CT in 12 patients (overall sensitivity, 44%; 52% in patients evaluated at initial diagnosis), leading to tumor resection in all cases. The primary tumors were distributed and graded as follows: 1 duodenum G2 lesion, 7 ileum G2 lesions, 2 terminal ileum G1 lesions, 1 pancreas G2 lesion, and 1 gallbladder G3 lesion. Patients with positive 18F-FDOPA PET/CT results had higher values of serum chromogranin A (100% vs. 20%, P = 0.0003), serotonin, or urinary 5-hydroxyindolacetic acid (83% vs. 20%, P = 0.003). Two false-negative results were related to poorly differentiated duodenal and prostatic NETs (G3). 18F-FDOPA PET/CT showed more metastatic anatomic regions than SRS in 17 patients. Conclusion: 18F-FDOPA PET appears to be a sensitive functional imaging tool for the detection of primary NETs occult on SRS, especially tumors with a well-differentiated pattern and serotonin secretion.
Journal of Materials Chemistry | 2009
Frédéric Lerouge; Oleg Melnyk; Jean-Olivier Durand; Laurence Raehm; Patrick Berthault; Gaspard Huber; Hervé Desvaux; André Constantinesco; Philippe Choquet; Julien Detour; Monique Smaïhi
The synthesis and functionalisation of zeolite nanoparticles designed for laser-polarized 129Xe NMR experiments in solution are described. These nanoparticles were functionalized by using original synthesis pathways through semicarbazide COCHO chemistry in order to ensure anchoring of a peptide for targeting biological receptors and attachment of PEG chains for in vivo experiments. Results demonstrated that accessibility of the dissolved noble gas to the micropores was maintained after functionalization. γ Scintigraphy with 111In linked to the zeolite particles has been investigated in order to follow the behaviour of the zeolite nanoparticles in mice. These preliminary 111In scintigraphy experiments showed the localization of the nanoparticles after injection in mice and their biodistribution, as a first proof-of-concept towards in vivo129Xe MRI.
Journal of Neuroscience Methods | 2011
Julien Detour; Karim Elbayed; Martial Piotto; François-Marie Moussallieh; Astrid Nehlig; Izzie-Jacques Namer
High resolution magic-angle spinning (HRMAS) NMR spectroscopy is a well established technique for ex vivo metabolite investigations but experimental factors such as ischemic delay or mechanical stress due to continuous spinning deserve further investigations. Cortical brain samples from rats that underwent ultrafast in vivo microwave irradiation (MWp group) were compared to similar samples that underwent standard nitrogen freezing with and without exposure to domestic microwaves (FN and FN+MWd groups). One dimensional (1)H HRMAS NMR spectra were acquired and 16 metabolites of interest were quantified. Within each group 3 samples underwent long lasting acquisition (up to 15 h). Statistically significant differences in metabolite concentrations were observed between groups for metabolites associated to post mortem biochemical changes and/or anaerobic glycolysis including several neurotransmitters. Spectral assessment over time showed a drastic reduction of biochemical variations in both MW groups. Only 2/16 metabolites exhibited significant signal variations after 15 h of continuous spinning and acquisition in the MWp group. This number increased to 10 in the FN group. We confirmed limited anaerobic metabolism and post mortem degradation after ultra fast in vivo MW irradiation. Furthermore, spectra obtained after MWp and MWd irradiation exhibited an extremely stable spectral pattern over extended periods of continuous acquisition.
Clinical Nuclear Medicine | 2010
Alessio Imperiale; Michel Greget; Gérard Chabrier; Julie Keomany; Edmond Rust; Julien Detour; Patrick Pessaux; Bernard Goichot
Abstract:Medullary thyroid carcinoma (MTC) is an uncommon malignant endocrine tumor. Distant metastases occur frequently in patients with elevated serum calcitonin values. Surgery remains the mainstay of treatment, so the early detection of metastatic involvement is crucial for patient outcome. F-18
The Journal of Nuclear Medicine | 2017
Julien Detour; Alice Pierre; Frederic Boisson; Guillaume Kreutter; Thomas Lavaux; I.J. Namer; L. Kessler; David Brasse; Patrice Marchand; Alessio Imperiale
Patient premedication with carbidopa seems to improve the accuracy of 6-18F-fluoro-3,4-dihydroxy-l-phenylalanine (18F-FDOPA) PET for insulinoma diagnosis. However, the risk of PET false-negative results in the presence of carbidopa is a concern. Consequently, we aimed to evaluate the effect of carbidopa on 18F-FDOPA uptake in insulinoma β-cells and an insulinoma xenograft model in mice. Methods: 18F-FDOPA in vitro accumulation was assessed in the murine β-cell line RIN-m5F. In vivo small-animal PET experiments were performed on tumor-bearing nude mice after subcutaneous injection of RIN-m5F cells. Experiments were conducted with and without carbidopa pretreatment. Results: Incubation of RIN-m5F cells with 80 μM carbidopa did not significantly affect the cellular accumulation of 18F-FDOPA. Tumor xenografts were clearly detectable by small-animal PET in all cases. Insulinoma xenografts in carbidopa-treated mice showed significantly higher 18F-FDOPA uptake than those in nontreated mice. Regardless of carbidopa premedication, the xenografts were characterized by an early increase in 18F-FDOPA uptake and then a progressive reduction over time. Conclusion: Carbidopa did not influence in vitro 18F-FDOPA accumulation in RIN-m5F cells but improved insulinoma imaging in vivo. Our findings increase current knowledge about the 18F-FDOPA uptake profile of RIN-m5F cells and a related xenograft model. To our knowledge, the present work represents the first preclinical research specifically focused on insulinomas, with potential translational implications.
Journal of Nuclear Cardiology | 2007
Sébastien Cimarelli; Alessio Imperiale; Dorra Ben-Sellem; Jérôme Rischner; Julien Detour; Olivier Morel; Patrick Ohlmann; André Constantinesco
Archive | 2013
Martial Piotto; François-Marie Moussallieh; Alessio Imperiale; Malika A. Benahmed; Julien Detour; Jean-Pierre Bellocq; Izzie Jacques Namer; Karim Elbayed
Annals of Nuclear Medicine | 2016
Mehdi Helali; Pietro Addeo; Céline Heimburger; Julien Detour; Bernard Goichot; Philippe Bachellier; I.J. Namer; David Taïeb; Alessio Imperiale
Clinical Nuclear Medicine | 2013
Alessio Imperiale; José Facundo Cabral; Edmond Rust; Guadalupe Flores-Turk; Caroline Renard; Fabrice Hubele; Julien Detour; H. Lang; Afshin Gangi; Izzie-Jacques Namer
Revue Neurologique | 2012
Julien Detour; Izzie-Jacques Namer; Stéphane Kremer; Jérôme De Seze